Your browser doesn't support javascript.
loading
Repurposed molecules for antiepileptogenesis: Missing an opportunity to prevent epilepsy?
Klein, Pavel; Friedman, Alon; Hameed, Mustafa Q; Kaminski, Rafal M; Bar-Klein, Guy; Klitgaard, Henrik; Koepp, Mathias; Jozwiak, Sergiusz; Prince, David A; Rotenberg, Alexander; Twyman, Roy; Vezzani, Annamaria; Wong, Michael; Löscher, Wolfgang.
Afiliação
  • Klein P; Mid-Atlantic Epilepsy and Sleep Center, Bethesda, Maryland.
  • Friedman A; Departments of Physiology and Cell Biology, and Brain and Cognitive Science, Zlotowski Center for Neuroscience, Ben-Gurion University of the Negev, Beer-Sheva, Israel.
  • Hameed MQ; Departments of Medical Neuroscience and Brain Repair Center, Dalhousie University, Halifax, Canada.
  • Kaminski RM; Neuromodulation Program, Division of Epilepsy and Clinical Neurophysiology, Department of Neurology, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts.
  • Bar-Klein G; Neurosymptomatic Domains Section, Roche Pharma Research & Early Development, Roche Innovation Center, Basel, Switzerland.
  • Klitgaard H; McKusick-Nathans Institute of Genetic Medicine, Howard Hughes Medical Institute, Johns Hopkins University School of Medicine, Baltimore, Maryland.
  • Koepp M; Neurosciences Therapeutic Area, UCB Pharma, Braine-l'Alleud, Belgium.
  • Jozwiak S; Department of Clinical and Experimental Epilepsy, University College London Institute of Neurology, London, UK.
  • Prince DA; Department of Pediatric Neurology, Warsaw Medical University, Warsaw, Poland.
  • Rotenberg A; Neurology and the Neurological Sciences, Stanford University School of Medicine, Stanford, California.
  • Twyman R; Neuromodulation Program, Division of Epilepsy and Clinical Neurophysiology, Department of Neurology, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts.
  • Vezzani A; Amron Neuroscience, Darby, Montana.
  • Wong M; Department of Neuroscience, Mario Negri Institute for Pharmacological Research, Scientific Institute for Research and Health Care, Milan, Italy.
  • Löscher W; Department of Neurology, Washington University School of Medicine, St Louis, Missouri.
Epilepsia ; 61(3): 359-386, 2020 03.
Article em En | MEDLINE | ID: mdl-32196665
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Epilepsia Pós-Traumática / Fármacos Neuroprotetores / GABAérgicos / Epilepsia / Fatores Imunológicos / Anticonvulsivantes / Antioxidantes Tipo de estudo: Etiology_studies / Prognostic_studies Limite: Animals / Humans Idioma: En Revista: Epilepsia Ano de publicação: 2020 Tipo de documento: Article País de publicação: Estados Unidos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Epilepsia Pós-Traumática / Fármacos Neuroprotetores / GABAérgicos / Epilepsia / Fatores Imunológicos / Anticonvulsivantes / Antioxidantes Tipo de estudo: Etiology_studies / Prognostic_studies Limite: Animals / Humans Idioma: En Revista: Epilepsia Ano de publicação: 2020 Tipo de documento: Article País de publicação: Estados Unidos